Identifying common risk factors for primary cellulitis in a large-scale retrospective cohort study

Read full text
Authors: Philip Curman, Sören Dräger, Henning Olbrich, Gema Hernandez, Katja Bieber, Evelyn Gaffal, Birgit K. Kahle, Khalaf Kridin, Silke Szymczak, Ralf J. Ludwig
Cited by: 1
References: 27

Abstract

BACKGROUND: Lower-leg cellulitis imposes a substantial global and individual burden. Identifying risk factors for primary cellulitis is essential to inform prevention. Prior studies are limited by small sample sizes and inconsistent results. OBJECTIVE: To identify and quantify risk factors associated with lower-leg cellulitis. METHODS: We conducted a large retrospective cohort study using electronic health records from the U.S.-based TriNetX network. Predefined covariates were assessed via Cox proportional hazards and Kaplan-Meier analyses. RESULTS: The highest risk for cellulitis were imposed by leg ulcers (HR: 2.669, 95% CI: 2.607-2.733, P < 0.0001) and lymphedema (HR: 1.631, 95% CI: 1.584-1.680, P < 0.0001). Heart failure, venous insufficiency and varicosis, nicotine use, alcohol abuse, diabetes mellitus, White ethnicity, onychomycosis, tinea pedis, obesity, corticosteroid medication, low socioeconomic status, atopic dermatitis and male sex were all significantly associated with an increased risk for cellulitis. Age was associated with slightly increased risk, whereas immunosuppressants and neoplasms were not associated with changes in cellulitis risk. LIMITATIONS: Limitations include potential confounding, misclassification bias, limited generalizability, and U.S.-specific data. CONCLUSION: This study identified various risk factors for primary cellulitis, e.g. leg ulcer or lymphedema. These results aid in guiding targeted prevention strategies to mitigate the identified risks.

Fields of Study & Subjects

Streptococcal Infections and Treatments Orthopedic Infections and Treatments Rheumatoid Arthritis Research and Therapies

Publication details

Journal / source
International Journal of Infectious Diseases
Publisher
Elsevier BV
Volume
166
Pages
108494–108494
Publication date
20 February 2026
Language
EN